1. |
Homma S, Messé SR, Rundek T, et al. Patent foramen ovale. Nat Rev Dis Primers, 2016, 2: 15086.
|
2. |
Mojadidi MK, Zaman MO, Elgendy IY, et al. Cryptogenic stroke and patent foramen ovale. J Am Coll Cardiol, 2018, 71(9): 1035-1043.
|
3. |
中华医学会心血管内科分会, 中国医师协会心血管内科分会. 卵圆孔未闭预防性封堵术中国专家共识. 中国循环杂志, 2017, 32(3): 209-214.
|
4. |
Gonnah AR, Bharadwaj MS, Nassar H, et al. Patent foramen ovale: Diagnostic evaluation and the role of device closure. Clin Med (Lond), 2022, 22(5): 441-448.
|
5. |
Shi F, Sha L, Li H, et al. Recent progress in patent foramen ovale and related neurological diseases: A narrative review. Front Neurol, 2023, 14: 1129062.
|
6. |
Kumar P, Kijima Y, West BH, et al. The connection between patent foramen ovale and migraine. Neuroimaging Clin N Am, 2019, 29(2): 261-270.
|
7. |
Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet, 2015, 386(9995): 743-800.
|
8. |
Del Sette M, Angeli S, Leandri M, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: A case-control study. Cerebrovasc Dis, 1998, 8(6): 327-330.
|
9. |
Kolte D, Palacios IF. Patent foramen ovale closure for secondary prevention of cryptogenic stroke. Expert Rev Cardiovasc Ther, 2021, 19(3): 211-220.
|
10. |
Cao Q, Shen Y, Hou Z, et al. The relationship between patent foramen ovale and unexplained dizziness: A prospective analysis in China. Neuropsychiatr Dis Treat, 2022, 18: 1495-1505.
|
11. |
Badea RŞ, Ribigan AC, Grecu N, et al. Differences in clinical and biological factors between patients with PFO-related stroke and patients with PFO and no cerebral vascular events. Front Neurol, 2023, 14: 1104674.
|
12. |
Bridges ND, Latson L, Filiano J, et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation, 1992, 86(6): 1902-1908.
|
13. |
Rao PS. Outcomes of device closure of atrial septal defects. Children (Basel), 2020, 7(9): 111.
|
14. |
Sperlongano S, Giordano M, Ciccarelli G, et al. Advances in percutaneous patent foramen ovale closure: From the procedure to the echocardiographic guidance. J Clin Med, 2022, 11(14): 4001.
|
15. |
Collado FMS, Poulin MF, Murphy JJ, et al. Patent foramen ovale closure for stroke prevention and other disorders. J Am Heart Assoc, 2018, 7(12): e007146.
|
16. |
中国医师协会心血管内科医师分会结构性心脏病学组, 心源性脑卒中人群的高危预测模型及治疗策略的临床研究课题组. 卵圆孔未闭超声诊断中国专家共识. 中国介入心脏病学杂志, 2023, 31(1): 4-11.
|
17. |
Gaspardone A, De Marco F, Sgueglia GA, et al. Novel percutaneous suture-mediated patent foramen ovale closure technique: Early results of the NobleStitch EL Italian Registry. EuroIntervention, 2018, 14(3): e272-e279.
|
18. |
Beneduce A, Ancona MB, Moroni F, et al. A systematic transoesophageal echocardiography study of suture-mediated percutaneous patent foramen ovale closure. EuroIntervention, 2022, 18(1): 63-67.
|